The results showed that patients with high-level nuclear expression of Id-1 in their primary ESCC were at a higher risk to develop distant metastasis within 1 year (odds ratio: 4.615, 95% confidence interval (CI): 1.596−13.348, P=0.005). This evidence concerns the gene ID1 and esophageal squamous cell carcinoma.